SRPT - Company ID 0000873303
The table below shows Sarepta Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $464.45M | $613.08M | $510.60M | $240.87M | $197.85M | $383.62M |
| Short-term investments | $188.74M | $237.92M | $289.54M | $281.89M | $1.00B | $1.08B |
| Receivables | $394.82M | $395.74M | $527.29M | $659.37M | $434.52M | $360.00M |
| Inventory | $1.00B | $1.08B | $994.04M | $941.43M | $565.92M | $485.80M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets | $2.31B | $2.72B | $2.66B | $2.43B | $2.69B | $2.68B |
| Property, plant & equipment | $336.24M | $358.94M | $371.86M | $360.59M | $305.79M | $276.20M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.18B | $3.49B | $3.68B | $3.47B | $3.60B | $3.42B |
| Accounts payable | $70.38M | $94.02M | $136.70M | $156.10M | $118.77M | $107.42M |
| Total current liabilities | $499.16M | $921.42M | $919.95M | $605.59M | $699.49M | $688.49M |
| Long-term debt | $838.16M | $1.04B | - | - | $1.23B | $1.23B |
| Total liabilities | $1.67B | $2.17B | $2.32B | $2.32B | $2.38B | $2.35B |
| Retained earnings | -$4.55B | -$4.64B | -$4.46B | -$4.66B | -$4.37B | -$4.40B |
| Total equity | $1.51B | $1.32B | $1.36B | $1.14B | $1.22B | $1.08B |